Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults (Q40114912)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults
scientific article

    Statements

    Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults (English)
    0 references
    0 references
    0 references
    Nicole A Grunenberg
    Brittany J Sanchez
    M Anthony Moody
    Nicole Frahm
    Christine M Hay
    Paul A Goepfert
    Peter B Gilbert
    HIV Vaccine Trials Network (HVTN) 094 Study Group

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit